These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8625208)

  • 1. S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
    Witzig TE; Habermann TM; Kurtin PJ; Schroeder G; Stenson MJ; Greipp PR
    Cancer; 1995 Sep; 76(6):1059-64. PubMed ID: 8625208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.
    Witzig TE; Gonchoroff NJ; Greipp PR; Katzmann JA; Stenson MJ; Habermann TM; Colgan JP; Therneau TM; Banks PM
    Am J Clin Pathol; 1989 Mar; 91(3):298-301. PubMed ID: 2646907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index.
    Beauregard P; Witzig TE; Kurtin PJ; Greipp PR; Stenson MJ; Katzmann JA; Habermann TM; Wieand HS
    Hematol Pathol; 1991; 5(4):177-83. PubMed ID: 1794967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas.
    Mochen C; Giardini R; Costa A; Silvestrini R
    Cell Prolif; 1997 Jan; 30(1):37-47. PubMed ID: 9332493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity in non-Hodgkin's lymphomas. A comparison of the bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis.
    Sebo TJ; Roche PC; Witzig TE; Kurtin PJ
    Am J Clin Pathol; 1993 Jun; 99(6):668-72. PubMed ID: 8100680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of apoptotic cell death in non-Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression.
    Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsenga A; Patsouris E; Thomas-Tsagli E; Kittas C; Pangalis GA
    Histopathology; 1998 Sep; 33(3):240-7. PubMed ID: 9777390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
    Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
    J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
    Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
    Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
    Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
    Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivariate study of non Hodgkin's lymphoma involving proliferation, apoptosis, bcl-2 and the microenvironment.
    Shetty V; Mundle S; Sanoy A; Sanghvi R; Loew J; Marcus B; Showel J; Gregory S; Raza A
    Leuk Lymphoma; 1995 Jul; 18(3-4):273-9. PubMed ID: 8535193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of DNA topoisomerase IIalpha expression provides independent prognostic information in non-Hodgkin's lymphomas.
    Korkolopoulou P; Angelopoulou M; Siakantari M; Mitropoulos F; Vassilakopoulos T; Zorzos H; Rassidakis G; Androulaki A; Patsouris E; Kittas C; Davaris P; Pangalis GA
    Histopathology; 2001 Jan; 38(1):45-53. PubMed ID: 11135046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo determination of cell cycle kinetics of non-Hodgkin's lymphomas using iododeoxyuridine and bromodeoxyuridine.
    Yanik G; Yousuf N; Miller MA; Swerdlow SH; Lampkin B; Raza A
    J Histochem Cytochem; 1992 May; 40(5):723-8. PubMed ID: 1573252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomas.
    Lindh J; Lenner P; Osterman B; Roos G
    Eur J Haematol; 1993 May; 50(5):258-63. PubMed ID: 8319787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry.
    Brons PP; Raemaekers JM; Bogman MJ; van Erp PE; Boezeman JB; Pennings AH; Wessels HM; Haanen C
    Blood; 1992 Nov; 80(9):2336-43. PubMed ID: 1421404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.